Detalhe da pesquisa
1.
Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.
Liver Transpl
; 29(12): 1313-1322, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37367954
2.
Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.
Liver Int
; 42(2): 350-362, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34679242
3.
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.
Liver Int
; 42(11): 2428-2441, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35924452
4.
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
J Hepatol
; 74(5): 1109-1116, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33307138
5.
Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease.
Liver Int
; 40(3): 581-589, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31749300
6.
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(2): 282-296, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30665869
7.
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.
J Hepatol
; 71(2): 389-396, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31102719
8.
Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification.
Clin Gastroenterol Hepatol
; 17(1): 164-171.e5, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29753082
9.
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Am J Gastroenterol
; 114(6): 916-928, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31169533
10.
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
Hepatology
; 65(4): 1145-1155, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27639088
11.
Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography.
J Pediatr Gastroenterol Nutr
; 66(3): 455-460, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29112089
12.
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.
J Hepatol
; 67(3): 577-584, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28506907
13.
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.
J Hepatol
; 66(5): 1022-1030, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28039099
14.
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
Hepatology
; 63(6): 1817-27, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26659452
15.
Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy.
Dig Dis Sci
; 62(9): 2569-2577, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28577247
16.
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
J Hepatol
; 65(3): 570-8, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27151181
17.
Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
J Gastroenterol Hepatol
; 31(4): 848-55, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26514665
18.
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.
J Hepatol
; 60(5): 1026-31, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24378529
19.
Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.
J Hepatol
; 61(3): 550-7, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24815876
20.
Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.
Hepatology
; 55(6): 1766-75, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22234932